Structure-Activity Relationship Study of Cyclic Pentapeptide Ligands for Atypical Chemokine Receptor 3 (ACKR3)

被引：3

作者：

Sekiguchi, Haruka ^{[1
]}

Kuroyanagi, Tomoko ^{[1
]}

Rhainds, David ^{[2
,3
]}

Kobayashi, Kazuya ^{[4
]}

Kobayashi, Yuka ^{[1
]}

Ohno, Hiroaki ^{[1
]}

Heveker, Nikolaus ^{[2
,3
]}

Akaji, Kenichi ^{[4
]}

Fujii, Nobutaka ^{[1
]}

Oishi, Shinya ^{[1
]}

机构：

[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan

[2] Univ Montreal, Dept Biochim, Montreal, PQ H3T 1J4, Canada

[3] Univ Montreal, St Justine Hosp, Res Ctr, Montreal, PQ H3T 1C5, Canada

[4] Kyoto Pharmaceut Univ, Yamashina Ku, Kyoto 6078412, Japan

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2018年 / 61卷 / 08期

基金：

加拿大健康研究院;

关键词：

CXCR4/CXCR7/CXCL12; PATHWAY; CXCR4; ANTAGONISTS; PROSTATE-CANCER; MIGRATION; CXCL12/SDF-1; TC14012; GROWTH; CELLS; RDC1;

D O I：

10.1021/acs.jmedchem.8b00336

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The atypical chemokine receptor 3 (ACKR3)/CXC chemokine receptor 7 (CXCR7) recognizes stromal cell derived factor 1 (SDF-1)/CXCL12 and is involved in a number of physiological and pathological processes. Here, we investigated the SAR of the component amino acids in an ACKR3-selective ligand, FC313 [cyclo(-D-Tyr-L-Arg-L-MeArgL-Nal(2)-L-Pro-)], for the development of highly active ACKR3 ligands. Notably, modification at the L-Pro position with toward ACKR3. a bulky hydrophobic side chain led to improved bioactivity toward ACKR3.

引用

页码：3745 / 3751

页数：7

共 50 条

[1] Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3)
Dekkers, Sebastian
Comez, Dehan
Karsai, Noemi
Arimont-Segura, Marta
Canals, Meritxell
Caspar, Birgit
de Graaf, Chris
Kilpatrick, Laura E.
Leurs, Rob
Kellam, Barrie
Hill, Stephen J.
Briddon, Stephen J.
Stocks, Michael J.
ACS MEDICINAL CHEMISTRY LETTERS, 2023, 15 (01): : 143 - 148
[2] Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases
Duval, Vincent
Alayrac, Paul
Silvestre, Jean-Sebastien
Levoye, Angelique
FRONTIERS IN ENDOCRINOLOGY, 2022, 13
[3] Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology
Quinn, K. E.
Mackie, D. I.
Caron, K. M.
CYTOKINE, 2018, 109 : 17 - 23
[4] Atypical Roles of the Chemokine Receptor ACKR3/CXCR7 in Platelet Pathophysiology
Chatterjee, Madhumita
CELLS, 2022, 11 (02)
[5] Atypical regulation of an atypical chemokine receptor: ACKR3 'senses' CXCR4 activation through phosphorylation
Schafer, Christopher T.
Chen, Qiuyan
Tesmer, John J.
Handel, Tracy M.
BIOPHYSICAL JOURNAL, 2023, 122 (03) : 479A - 479A
[6] Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts
Azad, Babak Behnam
Lisok, Ala
Chatterjee, Samit
Poirier, John T.
Pullambhatla, Mrudula
Luker, Gary D.
Pomper, Martin G.
Nimmagadda, Sridhar
JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (06) : 981 - 988
[7] Deletion of atypical chemokine receptor 3 (ACKR3) increases immune cells at the fetal-maternal interface
Quinn, Kelsey E.
Matson, Brooke C.
Caron, Kathleen M.
PLACENTA, 2020, 95 : 18 - 25
[8] Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System
Koenen, Joyce
Bachelerie, Francoise
Balabanian, Karl
Schlecht-Louf, Geraldine
Gallego, Carmen
MOLECULAR PHARMACOLOGY, 2019, 96 (06) : 809 - 818
[9] Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12
Benredjem, Besma
Girard, Melanie
Rhainds, David
St-Onge, Genevieve
Heveker, Nikolaus
JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (01) : 31 - 42
[10] Cryo-EM Structure of Atypical Chemokine Receptor 3 (ACKR3) in Complex with its Endogenous Ligand CXCL12
Yen, Yu-Chen
Schafer, Christopher
Gustavsson, Martin
Dominik, Pawel
Kossiakoff, Martin
Handel, Tracy
Tesmer, John
FASEB JOURNAL, 2021, 35

← 1 2 3 4 5 →